Bart A. Lutterbach
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Retinoids in leukemia and cellular processes
- Melanoma and MAPK Pathways
- Genomics and Chromatin Dynamics
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 11
-
- Protein Kinase Regulation and GTPase Signaling 7
- PI3K/AKT/mTOR signaling in cancer 6
- Retinoids in leukemia and cellular processes 5
- Protein Degradation and Inhibitors 4
- Genomics and Chromatin Dynamics 4
- Histone Deacetylase Inhibitors Research 4
- Co-authors
- Scott W. Hiebert (14 shared papers)Stephan Hann (6 shared papers)Lenora J. Davis (4 shared papers)Bryan E. Linggi (4 shared papers)Jennifer J. Westendorf (4 shared papers)Joseph M. Amann (4 shared papers)Harold Hatch (2 shared papers)Edward Seto (2 shared papers)
- Journals
- Molecular and Cellular Biology (9 papers)Cancer Research (3 papers)Journal of Biological Chemistry (3 papers)Oncogene (3 papers)Cancer Discovery (2 papers)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Bart A. Lutterbach
32 papers receiving 4.0k citations
Bart A. Lutterbach's Hit Papers
Peers
Comparison fields: 5 of 98
- Hematology 1.1k
- Molecular Biology 3.1k
- Aging 78
- Oncology 876
- Hepatology 244
Countries citing papers authored by Bart A. Lutterbach
This map shows the geographic impact of Bart A. Lutterbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart A. Lutterbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart A. Lutterbach more than expected).
Fields of papers citing papers by Bart A. Lutterbach
This network shows the impact of papers produced by Bart A. Lutterbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart A. Lutterbach. The network helps show where Bart A. Lutterbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart A. Lutterbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors Hit paper breakdown → | 2013 | 566 |
| 2 | 1998 | 372 | |
| 3 | 2001 | 289 | |
| 4 | 2007 | 283 | |
| 5 | 2008 | 248 | |
| 6 | 2000 | 219 | |
| 7 | 1994 | 179 | |
| 8 | 2000 | 178 | |
| 9 | 1998 | 165 | |
| 10 | 2010 | 160 | |
| 11 | 2003 | 137 | |
| 12 | 1999 | 136 | |
| 13 | 2000 | 128 | |
| 14 | 1995 | 126 | |
| 15 | 1999 | 101 | |
| 16 | 1991 | 96 | |
| 17 | 2000 | 92 | |
| 18 | 2010 | 76 | |
| 19 | 1994 | 75 | |
| 20 | 2006 | 64 |
About Bart A. Lutterbach
Bart A. Lutterbach is a scholar working on Hematology, Molecular Biology, Hepatology, Oncology and Cell Biology, having authored 32 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Retinoids in leukemia and cellular processes (5 papers), Liver physiology and pathology (5 papers), Protein Degradation and Inhibitors (4 papers), Genomics and Chromatin Dynamics (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (1.1k citations), Molecular Biology (3.1k citations), Aging (78 citations), Oncology (876 citations) and Hepatology (244 citations). Bart A. Lutterbach has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Scott W. Hiebert, Stephan Hann, Lenora J. Davis, Bryan E. Linggi, Jennifer J. Westendorf, Joseph M. Amann, Harold Hatch, Edward Seto, James R. Downing and Bo‐Sheng Pan. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Journal of Biological Chemistry, Oncogene and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.